
Journal of Medicinal Chemistry p. 2525 - 2533 (1992)
Update date:2022-07-30
Topics:
Tucker, Thomas J.
Lumma, William C.
Payne, Linda S.
Wai, Jenny M.
Solms, S. Jane de
et al.
A series of HIV-1 protease inhibitors containing a novel hydroxyethyl secondary amine transition state isostere has been synthesized.The compounds exhibit a strong preference for the (R) stereochemistry at the transition state hydroxyl group.Molecular modeling studies with the prototype compound 11 have provided important insights into the structural requirements for good inhibitor-active site binding interaction.N-Terminal extension of 11 into the P2-P3 region led to the discovery of 19, the most potent enzyme inhibitor in the series (IC50 = 5.4 nM). 19 was shown to have potent antiviral activity in cultured MT-4 human T-lymphoid cells.Comparison of analogs of 19 with analogs of 1 (Ro31-8959) demonstrates that considerably different structure-activity relationships exist between these two subclasses of hydroxyethylamine HIV-protease inhibitors.
View MoreZhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Shanghai Sharing technologies Co., Ltd.
Contact:86-021-66787223
Address:No11, Lane 225, Jinxiang Road,Pudong district
Contact:+33-5-34012600
Address:28 ZA des Pignès
Henan Techway Chemical Co.,Ltd.
website:http://www.techwaychem.com
Contact:+86-371-66380080
Address:No.27 Shunhe Road,
Doi:10.1055/s-0032-1317700
(2013)Doi:10.1021/om00044a005
(1992)Doi:10.1016/j.cclet.2013.01.037
(2013)Doi:10.1016/j.bmcl.2012.12.010
(2013)Doi:10.1016/j.bioorg.2018.09.028
(2018)Doi:10.3390/molecules21030232
(2016)